Tag: chemistry
-
Platform Devised for 3-D Engineered Heart, Liver Tissue
8 March 2016. An engineering team at University of Toronto designed and tested in lab animals a technology for growing synthetic heart and liver tissue for drug testing and eventual clinical use. Researchers led by chemical engineering professor Milica Radisic published their findings yesterday (7 March) in the journal Nature Materials; paid subscription required. Radisic…
-
Pain Medication Given FDA Breakthrough Tag
22 February 2016. A new drug to treat moderate to severe pain, now in clinical trials, received a breakthrough designation from the U.S. Food and Drug Administration. The drug, oliceridine, is made by Trevena Inc. in King of Prussia, Pennsylvania. Oliceridine addresses the same pain signals as opioid drugs that affect areas of the brain…
-
Vaccine Developed to Stop Synthetic Opioids
17 February 2016. Fentanyl is a synthetic opioid drug for treating severe pain after surgery, and in some cases chronic pain, but is also highly addictive and increasingly abused, with growing numbers of overdose deaths. Researchers from Scripps Research Institute in La Jolla, California developed a vaccine that in lab mice prevents ingredients in fentanyl…
-
Start-Up Licensing Wayne State Neurological Discoveries
8 February 2016. Wayne State University is licensing research discoveries from its pharmacy school to a new enterprise for development as drugs to treat depression, post-traumatic stress disorder or PTSD, and other neurological disorders. Financial aspects of the agreement with Trimaran Pharma Inc. were not disclosed. The deal covers research by pharmaceutical sciences professor Aloke…
-
Sensor Quickly Detects Bacteria in Wounds
5 February 2016. An engineering and medical research team developed a miniaturized sensor that detects the presence of dangerous bacteria in wounds in less than a minute. Researchers led by Victoria Shanmugam of George Washington University’s medical school and engineering professor Edgar Goluch at Northeastern University published their findings in a recent (27 January) issue…
-
Material Hides Beta Cell Transplants From Immune Reaction
26 January 2016. Engineering and biochemical researchers developed a material that in lab animals holds and protects transplanted pancreatic beta cells against an immune reaction, a key advance in treatments for individuals with type 1 diabetes. Teams from Massachusetts Institute of Technology and other institutions published their findings about the material in the 25 January…
-
Bacterial Bonding Technique Devised to Simplify Vaccines
20 January 2016. Researchers at Oxford University developed and tested engineered proteins from bacteria that in lab tests make vaccine design simpler and more reliable. The team from the lab of biochemistry professor Mark Howarth published its proof-of-concept results in the 19 January issue of Scientific Reports. Howarth — with immunologists from Oxford’s Jenner Institute…
-
€50,000 Challenge Seeks New Gas Technologies
28 December 2015. A challenge competition from industrial gas developer Air Liquide asks researchers to devise new solutions for three sustainable applications of gas molecules. Each of the three challenges awards a cash prize of €50,000 ($US 55,000), and an opportunity to earn another €500,000 in funding to develop the proposed solution. The competitions begin receiving entries on 6 January 2016,…
-
Bioactive Glass Reduces Decay in Tooth Cavity Fillings
23 December 2015. An engineering group at Oregon State University adapted a type of glass material that in lab models slows the decay in teeth with composite cavity fillings. The team led by materials engineering professor Jamie Kruzic published its findings in the January 2016 issue of the journal Dental Materials. Kruzic, with colleagues from…
-
Start-Up Licenses Founder’s Research for Resistant Bacteria
22 December 2015. A biotechnology company spun-off from University of California in San Diego is licensing technology from the university to develop treatments for bacterial infections now becoming resistant to conventional antibiotics. Financial terms of the licensing agreement between UC-San Diego and Forge Therapeutics were not disclosed. Forge Therapeutics, also in San Diego, is licensing…